Resultados de la búsqueda 31-40 of 7573 for Drug

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

  2. Drogadicción (trastorno de consumo de sustancias) - Diagnóstico y tratamiento - Mayo Clinic

    Commonly used drugs charts. National Institute on Drug Abuse. https://www.drugabuse.gov/drug-topics/commonly-used-drugs-charts. Accessed Aug. 16, 2022 ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

  5. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

  6. Oncología (médica) - Ensayos clínicos

    ... drug is on its own and in combination with other anti-cancer drugs (bevacizumab, cemiplimab, fianlimab and a standard chemotherapy drug, pegylated liposomal ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of a ...

  9. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

  10. Oncología (médica) - Ensayos clínicos

    ... drug is on its own and in combination with other anti-cancer drugs (bevacizumab, cemiplimab, fianlimab and a standard chemotherapy drug, pegylated liposomal ...